.png)
What RISA is building is not just smart technology. It removes barriers so our teams can move faster and stay focused on what matters most: caring for patients.

Dr. Jeff Vacirca
Chief Executive Officer
%201%20(1).png)
.png)
The work of 12 FTEs. Done by 5.
RISA has been a strong partner in supporting our growth. Our Part D prior auth volume increased by 35%, a level that would typically require 12 FTEs, yet we've been able to manage it efficiently with just 5.

Todd O'Connell
President
%201%20(1).png)
.png)
After 20+ years in authorizations, RISA is one of the most helpful systems I've used. It simplifies workflows, improves visibility, and makes managing cases far easier. When I’ve shown it to other team members, their reaction has been, ‘Where has this been all my life?’, that really reflects the value it brings.

Maria Langhorst
Senior Manager, RCM
.png)
.png)
Full visibility into every authorization!
We are extremely happy with what RISA is doing. My team now has complete insight into volumes, denials, turnaround times, and clinical alignment.

Dr. Edward Licitra, MD
Chief Executive Officer

.png)
RISA is the safety net.
In oncology, drug risk is existential. A tool like RISA acts as a safety net, automating the authorization workflow end-to-end so we shorten time to treatment, reduce errors, and take pressure off staffing.

Nirav Shah
Chief Revenue Officer
.png)
.png)
Patients get to scans faster.
Auths now close same-day.
RISA frees up team capacity by handling time consuming authorizations, letting coordinators focus on outreach, scheduling, and coordination. Turnaround is now same/next day, moving patients to scans faster and more efficiently.

Jake Canavan
Program Manager
